CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Primary Objective:Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).Secondary Objectives:Eva...
Phase 3
Portland, Oregon, United States and 29 other locations
Researchers are looking for a better way to treat people with chronic kidney disease (CKD), a progressive decrease in the kidneys...
Phase 3
Portland, Oregon, United States and 80 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Portland, Oregon, United States and 141 other locations
Researchers are looking for a better way to treat children who have chronic kidney disease (CKD), which is long-term kidney...
Phase 3
Portland, Oregon, United States and 145 other locations
The main purpose of this study is to compare the Human Acellular Vessel (HAV) with arteriovenous fistula (AVF) when used for hemodialysis access
Phase 3
Portland, Oregon, United States and 30 other locations
The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabete...
Phase 3
Portland, Oregon, United States of America and 390 other locations
of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) ...
Phase 3
Portland, Oregon, United States and 70 other locations
This is a multicenter, international, three-part, Phase 1 study designed to evaluate the safety, tolerability, and PK of rising single doses of AT-02...
Phase 1
Portland, Oregon, United States and 10 other locations
All patients will receive IL-2 (14 planned doses with an additional cycle 14 days after the first). Responding patients with regressing disease...
Phase 2
Portland, Oregon, United States
and atezolizumab after they experience radiographic progressive disease per the Investigator per RECIST 1.1. Due to the nature of this study...
Phase 1, Phase 2
Portland, Oregon, United States and 123 other locations
Clinical trials
Research sites
Resources
Legal